# ARomatherapy for Cognitive Trajectory in Chinese After Percutaneous Coronary Intervention (ARCTIC-PCI)

> **NCT04103086** · NA · UNKNOWN · sponsor: **Beijing Anzhen Hospital** · enrollment: 660 (estimated)

## Conditions studied

- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Aromatherapy
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04103086
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2020-12
- **Final completion:** 2021-06
- **Target enrollment:** 660 (ESTIMATED)
- **Last updated:** 2019-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04103086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04103086, "ARomatherapy for Cognitive Trajectory in Chinese After Percutaneous Coronary Intervention (ARCTIC-PCI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04103086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*